• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    25.91 Down 0.13(0.50%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:26.04
    Open:26.16
    Bid:0.01 x 100
    Ask:31.87 x 100
    1y Target Est:26.83
    Beta:-0.07
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:25.37 - 26.71
    52wk Range:19.10 - 47.65
    Volume:464,404
    Avg Vol (3m):658,498
    Market Cap:739.45M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 0.50%739.45M
    AZNDown 0.19%88.34B
    MRKUp 1.02%165.58B
    PFEUp 1.36%214.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.51
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-3.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback